Manténgase sano!

Report Finds Drug Prices Rising Despite Trump Pricing Deals

A new U.S. Senate report, released by Sen. Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to raise prices on hundreds of meds. 

Some new drugs are also launching with very high costs, NBC News reported.

On average, new drugs carried a price tag of about $353,...

Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog

Brain fog is a common side effect of chemotherapy for cancer, with the toxic drug cocktails affecting attention, memory and ability to multitask.

But a couple of cheap, simple solutions — low-dose ibuprofen and exercise — appear to be effective in protecting cancer patients’ brain function during chemo, researchers report...

E-Cigarette Taxes Won't Necessarily Cause An Increase In Smoking, Study Says

Regulators have long been reluctant to tax e-cigarettes, worried that higher prices might unintentionally drive vapers back to tobacco cigs.

But a new study suggests those fears might be misplaced, at least where adult vapers are concerned.

Higher prices reduced e-cigarette use among a nationwide sample of 700 adult vapers, and somet...

Weed Blunts Brain Development In Teens

Weed can blunt teenagers’ brain development across a range of skills, including memory, attention, language and processing speed, a new study says.

Teenagers who started using weed had slower gains in thinking and memory skills as they grew, researchers report today in the journal Neuropsychopharmacology.

“Adoles...

Dreams Affect Your Morning Mood In Surprising Ways, Study Finds

Bad dreams can affect your morning mood, but not if a little joy is sprinkled into your slumber, a new study says.

People who had dreams filled with fear were more likely to be in a rotten mood the following morning, researchers recently reported in the journal Sleep.

But if their dreams mixed fear and joy, sleepers had 20% ...

Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show

The overdose-reversing drug naloxone has been rightly hailed as a lifesaving breakthrough, saving countless lives from opioid ODs.

But a new study warns that the wonder drug has its limits, especially when confronted with overdoses involving the powerful new wave of synthetic opioids like fentanyl.

Naloxone may not fully reverse ODs ...

Extra Antibiotic Doesn't Reduce Infection Risk During Surgery To Fix Complex Fractures, Trial Finds

Adding an extra antibiotic powder doesn’t further reduce a person’s risk of infection during surgery to repair complex bone fractures, a new study says.

People had about the same rate of post-surgery infections whether doctors sprinkled one or two antibiotic powders into their surgical wound, researchers reported April 15 in th...

New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer

Immunotherapy has largely failed as a treatment for cancer of the pancreas, and researchers have zeroed in on a key reason.

Pancreatic tumors reprogram immune cells that normally shut down tumor-killing cells, according to a team at Oregon Health & Science University in Portland. 

"Pancreatic cancer is incredibly resistant t...

Does My Child Have a Language Disorder?

Baby’s first words are a source of pride for parents, but when they’re late in coming, it can be a source of worry.

While most kids catch up, those whose language troubles persist may have a condition called DLD.

Short for developmental language disorder, DLD can affect a child’s speech, as well as listening, readin...

New Weight Loss Research Questions Need for GLP-1 Drugs

A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?

In a new study published April 15 in the journal Molecular Metabolism, researchers tested a drug that targets two other hormones: GIP and glucagon. 

Th...

Trump Names CDC Director Pick

After months of leadership changes, President Donald Trump has chosen a new candidate to lead the U.S. Centers for Disease Control and Prevention (CDC).

The White House announced Thursday that Dr. Erica Schwartz, a physician and former deputy surgeon general, is the new nominee. 

"It is my Honor to nominate the incredibly talent...

Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest

A growing number of younger adults are dying from colon cancer, but the increase isn’t affecting everyone in the same way.

New research, published April 16 in JAMA Oncology, shows the rise in colon cancer deaths is happening mostly among adults without a four-year college degree. That suggests social and economic factors cou...

FDA To Review Whether To Allow More Access To Certain Peptides

The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.

Peptides are small chains of amino acids that are marketed for a wide range of uses, including treating wounds, obesity, insomnia and inflammatory conditions.

An FDA advisor...

Most People Would Take A Blood Test For Alzheimer's, Study Says

Most people would want to take a blood test that can assess their risk of Alzheimer’s disease, rather than remain anxious about their odds, a new study says.

About 85% of primary care patients said they’d take a blood test that looks for the toxic proteins linked to Alzheimer’s, according to a report published April 15 in...

Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says

Reaching for the salt shaker could have long-lasting implications for your memory and brain health, a new study says.

Higher sodium intake appears to affect episodic memory, the type of memory used to recall personal experiences and specific events from your past, researchers report in the June issue of the journal Neurobiology of Agin...